News | Proton Therapy | April 18, 2016

Offshoot of Delray Medical Center will use Varian ProBeam proton therapy system

Varian, proton therapy, ProBeam system, Delray Medical Center, South Florida

April 18, 2016 — Delray Medical Center, Delray Beach, Fla., has reached agreement with Proton International (PI) to build a one-room proton therapy treatment center serving the South Florida corridor.

Proton therapy, a form of radiation therapy, is a highly precise and effective treatment for many cancer tumors but without many of the side effects that often accompany treatment.

Delray will be among a select group of hospitals in the country to offer proton therapy using the most advanced technology available, a fully featured compact system with dynamic peak pencil beam scanning, developed by Varian Medical Systems.

“We are looking forward to offering this innovative treatment option at Delray Medical Center,” said Mark Bryan, CEO. “It is always our goal to incorporate new technologies and techniques that will make treatment safer and less invasive for our patients.”

“We are very pleased to team with Delray to assure broader access to this important cancer therapy. It will allow people to be treated in their community, close to family and friends,” said Chris Chandler, CEO of Proton International, which currently has proton centers under construction at Beaumont Hospital, Royal Oak, Mich., and the University Medical Center in Groningen, The Netherlands. “We selected Varian to be the proton system provider because Varian’s ProBeam system has unique capabilities making it the most complete single room proton system on the market.”

Proton therapy is particularly effective in treating solid cancer tumors, including tumors of the brain, spine, head and neck, lung, prostate, colon and some breast tumors. It is widely used to treat children with cancer because of its precision and lack of long-term side effects, as children are particularly sensitive to the effects of radiation therapy.

Pencil beam scanning gives physicians advanced options for delivering proton therapy precisely in order to minimize exposure to healthy tissue while delivering treatments. The scanning beam technology enables intensity-modulated proton therapy (IMPT) by adjusting dose levels on a spot-by-spot basis throughout the treatment area.

PI’s turnkey development significantly lowers project risk and provides access to long-term funding, making it easier and more affordable for hospitals, oncologists and other medical professionals to offer proton cancer therapy to patients in one- or two-room centers.

For more information: www.protonintl.com

Related Content

News | Nuclear Imaging

December 3, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring ...

Time December 03, 2021
arrow
News | Coronavirus (COVID-19)

December 2, 2021 — Almost two-thirds of U.S. states failed to prioritize cancer patients for COVID-19 vaccinations ...

Time December 02, 2021
arrow
Videos | Radiation Therapy

Jeffrey T. Chapman, a medical student at the University of Texas Southwestern Medical Center, Explains how watching ...

Time November 24, 2021
arrow
Videos | Radiopharmaceuticals and Tracers

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
Videos | Radiation Therapy

The Elekta Harmony radiotherapy system gained FDA clearance in the summer of 2021 and was on display for the first time ...

Time November 17, 2021
arrow
News | Radiation Therapy

November 17, 2021 — Radiation can be a powerful cancer therapy, but it doesn’t work for everyone. A new study identifies ...

Time November 17, 2021
arrow
Videos | Radiation Oncology

This is a model of the Toshiba ion beam radiation therapy system at the American Society of Radiation Oncology (ASTRO) ...

Time November 16, 2021
arrow
News | Prostate Cancer

November 16, 2021 — A new Harvey L. Neiman Health Policy Institute study of nearly 800,000 men found that between 2011 ...

Time November 16, 2021
arrow
Videos | Radiation Oncology

Walter Curran, Jr. M.D., FACR, FASCO, GenesisCare global chief medical officer, discusses three technologies that are ...

Time November 16, 2021
arrow
Videos | Radiation Oncology

This is an example of a multileaf collimator (MLC) on the Accuray Thomotherapy radiation therapy system at the American ...

Time November 16, 2021
arrow
Subscribe Now